UNAIDS welcomes US approval of drug to stop HIV

July 17, 2012

The UN agency tasked with fighting AIDS on Tuesday welcomed the decision by the United States to allow the use of an HIV prevention pill for the first time.

The pill will be used "to prevent the sexual transmission of HIV for people who do not have HIV, but who are at high risk of being exposed to the virus", UNAIDS said in a statement from its Geneva headquarters.

Since 2004, the combination of drugs contained in the pill -- and tenofovir disoproxil fumarate -- has been used to help those with HIV, but not to protect against infection, the agency said.

The (FDA) approved the pill -- known as Truvada -- on Monday based on results from clinical trials which found that a daily oral dose of tenofovir, or emtricitabine/tenofovir disoproxil fumarate, carried significant preventative benefits, UNAIDS said.

HIV prevention of this kind is called pre-exposure prophylaxis, or PrEP, which the FDA approved as part of a wider HIV prevention strategy that includes and other safer sex practices, risk reduction counselling and control of other sexually transmitted infections.

Explore further: AIDS drug trials may be virus stopper

Related Stories

AIDS drug trials may be virus stopper

May 18, 2006

A U.S. pharmaceutical company is trying to get complete human data on a drug proven to prevent HIV in monkeys more than 12 years ago.

Oral pill trial to halt HIV in women is stopped

April 19, 2011

A trial of an oral pill aimed at preventing HIV infection in African women has been halted due to poor results, the trial operator Family Health International announced this week.

AIDS: HIV drugs boost prevention hopes

July 13, 2011

Heterosexuals who take daily AIDS drugs reduce the risk of being infected by the human immunodeficiency virus (HIV) by nearly two-thirds, ground-breaking studies said on Wednesday.

NIH modifies 'VOICE' HIV prevention study in women

September 28, 2011

A large-scale clinical trial evaluating whether daily use of an oral tablet or vaginal gel containing antiretroviral drugs can prevent HIV infection in women is being modified because an interim review found that the study ...

Recommended for you

Mutational tug of war over HIV's disease-inducing potential

August 23, 2016

A study from Emory AIDS researchers shows how the expected disease severity when someone is newly infected by HIV reflects a balance between the virus' invisibility to the host's immune system and its ability to reproduce.

Dormant copies of HIV mostly defective, new study shows

August 8, 2016

After fully sequencing the latent HIV "provirus" genomes from 19 people being treated for HIV, scientists at Johns Hopkins Medicine report that even in patients who start treatment very early, the only widely available method ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.